Confirmatory Study Of NeoCart In Knee Cartilage Repair

Overview

About this study

This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Note: All pre-eligibility/ pre-screening testing and visits are billed to the patient.

Inclusion Criteria:

greater than 18 years to 59 years of age.
symptomatic articular cartilage lesion of the femur and/or trochlea

Exclusion Criteria:

prior surgical intervention other than debridement
arthritis
clinically significant or symptomatic vascular or neurologic disorder of the lower extremities

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Aaron Krych, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Aaron Krych, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials